Chronic obstructive pulmonary disease (COPD) and type 2 diabetes mellitus (T2DM) often coexist. The mechanistic links between these two diseases are complex, multifactorial, and not entirely understood, but they can influence the approach to treatment. Understanding whether COPD comes first followed by T2DM or vice versa, or whether the two diseases develop simultaneously due to common underlying mechanisms, is important for the development of novel therapeutic approaches to these two important diseases. In this review, we discuss the potential links between COPD and T2DM and pharmacological approaches that might target these links.

Cazzola, M., Rogliani, P., Calzetta, L., Lauro, D., Page, C., Matera, M.g. (2017). Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus. TRENDS IN PHARMACOLOGICAL SCIENCES, 38(10), 940-951 [10.1016/j.tips.2017.07.003].

Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus

Cazzola M.;Rogliani P.;Calzetta L.;Lauro D.;
2017-01-01

Abstract

Chronic obstructive pulmonary disease (COPD) and type 2 diabetes mellitus (T2DM) often coexist. The mechanistic links between these two diseases are complex, multifactorial, and not entirely understood, but they can influence the approach to treatment. Understanding whether COPD comes first followed by T2DM or vice versa, or whether the two diseases develop simultaneously due to common underlying mechanisms, is important for the development of novel therapeutic approaches to these two important diseases. In this review, we discuss the potential links between COPD and T2DM and pharmacological approaches that might target these links.
2017
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIO
Settore MED/13 - ENDOCRINOLOGIA
English
Con Impact Factor ISI
Chronic obstructive pulmonary disease; GLP1-R agonists; ROCK inhibitors; glycaemic control; systemic inflammation; type 2 diabetes mellitus; Animals; Diabetes Mellitus, Type 2; Humans; Pulmonary Disease, Chronic Obstructive
Cazzola, M., Rogliani, P., Calzetta, L., Lauro, D., Page, C., Matera, M.g. (2017). Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus. TRENDS IN PHARMACOLOGICAL SCIENCES, 38(10), 940-951 [10.1016/j.tips.2017.07.003].
Cazzola, M; Rogliani, P; Calzetta, L; Lauro, D; Page, C; Matera, Mg
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/191981
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 41
  • ???jsp.display-item.citation.isi??? 39
social impact